Results 161 to 170 of about 7,954 (256)

First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia. [PDF]

open access: yesJpn J Clin Oncol
Chung HJ   +17 more
europepmc   +1 more source

Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer. [PDF]

open access: yesJ Immunother Precis Oncol
Autio KA   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy